Venture capital

The UK's Small Business Investment Taskforce has looked into funding for high-tech businesses.

Merlin Biosciences has been under the cloud of an investigation by the UK's Serious Fraud Office. Now founder Chris Evans says the firm is planning new investments.

The number of venture-backed exits grew in value and number in 2005 – and the upward trends are expected to continue into 2007.

What's hot for for 2006? Spin-outs and carve-outs, says senior Atlas Venture partner Christopher Spray in an interview for Science|Business

A new high-accuracy low-cost infusion pump has attracted £250,000 funding from The Capital Fund, a £50 million venture capital fund that invests in fast-growth companies in Greater London.

Philips has announced the first fruit of its deal with the venture capital firm New Venture Partners to spin out companies based on research carried out in Philips’ corporate research laboratories.

The climate for R&D-based start-ups in Central and Eastern Europe should be improving. But there’s still a way to go, writes Mary Lisbeth D’Amico.

Venture capitalists are once again funding nanotech start-ups, but their overall investment is small compared with government funding and corporate R&D spending, says to a new report.

News Editor Thomas Lau spoke to Florian Schönharting, a partner at the Nordic Biotech, a fund that has invested in Denmark’s Gastrotech BipPharma - a biotechnology company that recently merged with US biotech firm DOR BioPharma. Nordic Biotech, a specialised biotech venture capital fund focusing primarily on Nordic countries and the EU, has invested in Gastrotech since its inception in March 2003.

We interview Andrew Newland, head of a venture capital consultancy with a long-term strategy of working with scientists and inventors.